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S U M M A R Y
Objectives: The primary objective of this study was to compare laboratory practices for screening blood
donors for syphilis at blood transfusion facilities in Ghana with the recommendations of the World
Health Organization and the National Blood Service, Ghana (NBSG). The prevalence of syphilis antibodies
in blood donors in Ghana was also estimated.
Methods: Over an 11-month period, from February 2014 to January 2015, a semi-structured
questionnaire was administered to 122 laboratory technical heads out of a total of 149 transfusion
facilities in Ghana. The response rate was 81.9%.
Results: A total of 58 (48%) transfusion facilities tested donors for syphilis, with an estimated 3.7%
seroprevalence (95% conﬁdence interval 3.6–3.8%). A total of 62 782 out of 91 386 (68.7%) donations
were tested with assays that are not recommended. The estimated syphilis seroprevalence in voluntary
donations was 2.9%, compared to 4.0% in family donations (p = 0.001). Only 6.9% of the health facilities
were using standard operating procedures (SOPs).
Conclusions: Despite international and national recommendations, more than half of the studied health
facilities that provide blood transfusions in Ghana are not screening blood donations for syphilis. These
data show a considerable mismatch between recommendations and practice, with serious consequences
for blood safety and public health.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Early reports of the transfusion-related transmission of syphilis
led to the World Health Organization (WHO) recommendations for
syphilis testing of blood donors.1 These recommendations have
been questioned, since many syphilis antibodies among blood
donors are the result of previous infections or even unspeciﬁc
reactions. Furthermore, Treponema pallidum does not withstand
cold storage.2 However, as not all blood components can be* Corresponding author at: Komfo Anokye Teaching Hospital, Transfusion
Medicine Unit Kumasi, Ghana. Tel.: +233244371770.
E-mail addresses: fsarkodie29@gmail.com (F. Sarkodie), ohassall@gmail.com
(O. Hassall), owusudabo@yahoo.com (E. Owusu-Dabo), sowusu_ofori@hotmail.com
(S. Owusu-Ofori), ibates@liverpool.ac.uk (I. Bates), iby@sund.ku.dk (I.C. Bygbjerg),
kordaiansah@yahoo.com (J.K. Ansah), henrik.ullum@regionh.dk (H. Ullum).
http://dx.doi.org/10.1016/j.ijid.2015.12.020
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).assumed to be kept cold for a sufﬁcient amount of time, if at all, and
as syphilis may also serve as a potential surrogate marker for high
risk behaviour in relation to HIV infection, syphilis screening
continues to be a requirement in many countries.
There have been several studies conducted in many African
countries indicating a high prevalence of syphilis antibodies
in healthy blood donors.3 The WHO recommends several
syphilis screening tests: the enzyme immunoassay (EIA)
and T. pallidum haemagglutination assay (TPHA) as speciﬁc
tests, or the Venereal Disease Reference Laboratory (VDRL)
and rapid plasma reagin (RPR) as non-speciﬁc screening
tests.4 Following a documented case of transfusion-transmit-
ted syphilis in Ghana in 2011,5 it was recommended that
syphilis testing for blood donors be implemented so that
recipients of blood transfusions would not be at risk of
contracting syphilis.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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main donor categories: voluntary non-remunerated donors
(VNRD) and family (replacement) donors (FD). Family donors –
who are individuals prompted to provide blood units to replace
blood transfused to their relatives or friends6 – remain dominant
on the African continent as a response to difﬁculties in recruiting
and attracting VNRD.7 However in Ghana, as elsewhere, there is a
higher proportion of syphilis seroreactive donations among FD
possibly because they are generally older than VNRD and possibly
because they are at higher sexual risk.8
Out of the many different categories of hospital in Ghana, a total
of 149 health facilities across the country practice blood
transfusion under the National Blood Service, Ghana (NBSG).
Three of the facilities are teaching hospitals located in the Greater
Accra, Ashanti, and Northern regions. Ghana has 10 administrative
regions and each of them has a regional hospital with bed
occupancy lower than the teaching hospitals. However, the
58 district hospitals are distributed unequally. The distribution
of the district hospitals is based on the level of development of the
region, so some regions have more transfusion centres than others.
Likewise, the other health facilities such as the 36 mission
hospitals, eight private hospitals, and seven clinics are distributed
unequally.
In Ghana, as in many other African countries, the purchase of
blood bank reagents is poorly regulated, with local blood banks
purchasing whatever reagents are available and affordable.
Additionally, the reagent cost per test for syphilis testing in Ghana
depends mainly on the bargaining power of the facility manage-
ment system in the open market. This decentralized purchasing
system may lead to increased costs of reagents, as well as failures
in quality and consistency. In addition to decentralized reagent
purchasing, the lack of written standard operating procedures
(SOPs) and effective transfusion-transmitted infection (TTI) guide-
lines for donor care may hamper quality and care. To ensure the
safety, efﬁcacy, and adequacy of blood and blood products for
patients, the Ghana National Blood Policy, which was approved by
the cabinet in 2006, states that all blood units collected must be
tested prior to transfusion for TTIs including syphilis, using
approved, well-controlled techniques and procedures and in
accordance with WHO guidelines. Furthermore, the NBSG should
be responsible for the purchasing of well-approved test kits before
use.
This survey compared current syphilis screening practices in
Ghana with the recommendations of the WHO and NBSG regarding
the use of assays for screening blood donors and their performance.
The prevalence of syphilis antibodies in blood donors was also
estimated. Additionally, the survey determined whether written
SOPs or guidelines were in place for syphilis screening and whether
donors with positive syphilis tests were referred for clinical
follow-up.
2. Materials and methods
It was intended to interview the laboratory technical heads of
all 149 transfusion facilities in Ghana between January 2014 and
February 2015 and to request their 2012 syphilis screening results.
The survey was conducted using a semi-structured questionnaire
administered by telephone call or e-mail. Contact numbers and
e-mail addresses were obtained from the NBSG headquarters in
Accra and other laboratory science colleagues in the various
transfusion facilities in the country. Seventy-three (60%) of the
technical heads responded immediately by telephone, while 24
(20%) of them were interviewed twice before providing all of the
information by telephone; 25 (20%) provided information through
a semi-structured questionnaire by e-mail. The total number ofnon-respondents was 27 (18.4%); most of these were in remote
areas.
2.1. Statistical analysis
Data from the interviews were collected using Epi Info version
3.5.3 (US Centers for Disease Control and Prevention, Atlanta, GA,
USA), transferred into an Excel spreadsheet, and exported into
Stata version 12.0 statistical software (StataCorp LP, College
Station, TX, USA) for analysis. Prevalence was estimated by
calculating proportions and providing their respective conﬁdence
intervals (95% CI).
2.2. Ethics statement
Approval for this survey was obtained from the ethics
committees of Kwame Nkrumah University of Science and
Technology (KNUST), Kumasi, Ghana (CHRPE/AP/423/13) and
the Liverpool School of Tropical Medicine, Liverpool, UK (18/02/
2014). Furthermore, an introductory letter was sent to all of the
respondents from the head of the NBSG, with the assurance of their
anonymity in the use of their data.
3. Results
3.1. Facilities and testing
Of a total of 149 health facilities known to be undertaking blood
transfusion, 122 (81.9%) responded to the inquiry. In 2012, the
total number of donations collected and screened for TTIs (HIV,
hepatitis B virus (HBV), and hepatitis C virus (HCV)) other than
syphilis from the 122 transfusion facilities responding to the
survey was 143 787 (Table 1). From the questionnaire adminis-
tered, it was found that none of the centres was using a second test
to re-screen syphilis-reactive donations.
The total number of transfusion facilities not screening for
syphilis was 64 (52%). When asked for the reasons, 49 facilities
(77%) reported a lack of funds to purchase reagents. Fourteen
facilities (21%) reported that although syphilis screening is
recommended, the refrigeration of blood units for more than
5 days kills T. pallidum. One transfusion facility (2%) reported that
screening for syphilis was not mandatory.
The total number of donations at the 58 (48%) transfusion
facilities screening for syphilis was 91 386 units, of which
3371 were syphilis antibody seroreactive, resulting in an estimated
seroprevalence of 3.7% (95% CI 3.6–3.8%). Of the facilities screening
for syphilis, two of the three (67%) teaching hospitals screened for
syphilis and contributed the highest percentage (40.4%) of the total
donations. Furthermore, eight of the 10 (80%) regional hospitals
screened for syphilis, but contributed only 17.7% (16 009/91 386)
to the total donations, whilst 12 of the 36 (33%) mission hospitals
screened for syphilis and contributed 15.4% (14 064/91 386) to the
total donations, as shown in Table 1. Among the seven clinics, only
three (43%) screened for syphilis and these contributed the least
(1%) donations. However, the teaching hospitals reported the
lowest syphilis rate of seroreactivity (3.2%), with the highest
coming from the mission facilities (4.4%). Notably, almost half of
the district hospitals did not test for syphilis.
3.2. Donor type and syphilis seroreactivity
The total number of donations screened for syphilis was 91 386
(63.6% of 143 787). The total number of voluntary donations
screened for syphilis was 26 180 (28.6%, 95% CI 28.4–28.9%), with
757 (2.9%) testing positive. Of the total of 65 206 (71.4%) family/
replacement donations, 2614 (4.0%) tested positive for syphilis
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FD in its totality for this survey was signiﬁcantly higher than the
rate from VNRD (p = 0.001). However, there were differences in
syphilis seroreactivity depending on the health facility in terms of
VNRD and FD: while there was no difference between VNRD and
FD in syphilis seroreactivity in the teaching facilities (Table 1),
there were differences in the other health facilities, where FD
seroreactivity was signiﬁcantly higher than VNRD seroreactivity,
except at the mission facilities, where VNRD seroreactivity was
signiﬁcantly higher than FD seroreactivity. However, the data
received from the transfusion centres across the country did not
indicate the sensitivity and speciﬁcity of the type of syphilis test
used.
3.3. Recommended assays and other assays for syphilis testing, and
operating them
Of the total donations screened for syphilis in this survey, 31.3%
were tested using a recommended assay (TPHA; Fortress
Diagnostics Limited, Antrim, UK). The non-recommended methods
used were all rapid diagnostic tests (RDTs), with 60% reporting
ACON as the brand name (ACON Laboratories, Inc., San Diego, USA).
Of the others, 19% reported First Response (Premier Medical
Corporation Limited, Kachigam, India), 12% ABON (Abon Biopharm
Company Limited, Hangzhou, China), 5% Fortress (Fortress
Diagnostics Limited, Antrim, UK), 3% Wondfo (Guangzhou Wondfo
Biotech, Guangzhou, China), and 1% Determine (Allere Medical
Company Limited, Matsuhidai, Japan).
Forty-seven percent of the transfusion facilities validated their
syphilis test kits before screening, while only 7% had written SOPs
(Table 2).
The hospital management of 52 (89.7%) transfusion facilities
purchased syphilis screening reagents on the open market
(Table 2). The variation in cost per test strip for syphilis screening
varied 10-fold, from US$ 0.2 to US$ 2.0.
3.4. Follow-up of syphilis seroreactive donors
Only 33 (56.9%) facilities referred syphilis-reactive blood
donors for clinical advice (Table 2).
4. Discussion
This survey aimed to describe syphilis screening practices and
seroprevalence for blood donors in transfusion facilities in Ghana.
The estimated national syphilis seroprevalence of 3.7% in this
survey is similar to that found among healthy blood donors
elsewhere in the region.9–11 The high occurrence of syphilis has
provoked a greatly heightened emphasis on safety, with signiﬁcant
implications in relation to complexity and cost. The study found
that about half of the studied facilities in Ghana were not screening
blood donations for syphilis, which could lead to syphilis
transmission through blood transfusion. Of those facilities that
were found to screen donated blood for syphilis, only a third used a
recommended test. Among those facilities that were screening,
half were not validating the kits, and of donors found to be syphilis-
seropositive, more than a third were not referred for further
clinical management.
Many parts of the world have reported syphilis seroreactivity
rates among FDs similar to that found in the present study.8,12,13
One reason for the high rates is that FDs are older and therefore
have had a longer time to acquire syphilis antibodies. However,
FDs may be under pressure to donate blood when their relatives
are admitted to hospital and in need of a blood transfusion, even
when they know that they are potentially at risk of sexually
transmitted diseases as a result of high-risk behaviours. They may
Table 2
Results of the syphilis screening survey in Ghana – 2012
Health
facilities
Number of
centres
that validated
test kitsa
n = 58, (%)
Number of
centres with
written SOPs
n = 58, (%)
Number of
centres that
referred for
clinical advice
n = 58, (%)
Proportion of
reagents purchased
by hospital
management
n = 58, (%)
Donations screened
with recommended
assays (TPHA)
n = 91 386, (%)
Non-recommended
assays (RDTs)
used at the
screening sites
Teaching 2 (3.4) 1 (1.7) 2 (3.4) 2 (3.4) 25 726 (69.6) Fortress
Regional 7 (12.1) 1 (1.7) 7 (12.1) 8 (13.8) 0 ACON, First Response,
and Determine
District 12 (20.7) 1 (1.7) 16 (31.0) 28 (48.3) 612 (3.8) ACON, ABON, First Response,
and Wondfo
Clinic 0 0 1 (1.7) 1 (1.7) 165 (18.8) ABON
Private 1 (1.7) 1 (1.7) 1 (1.7) 1 (1.7) 2062 (67.7) Syphilis ultra-rapid test
Mission 5 (8.6) 0 8 (13.8) 12 (20.7) 0 ACON and First Response
Total 27 (46.5) 4 (6.9) 33 (56.9) 52 (89.7) 28 565 (31.3)
SOPs, standard operating procedures; TPHA, Treponema pallidum haemagglutination assay; RDTs, rapid diagnostic tests.
a Validate: prove the efﬁciency of a test kit.
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sexual behaviours that predispose them to infections and thus pose
a threat to the safety of the blood supply. Despite this, family
donations remain dominant in the African continent because
family and community ties are often considerably stronger than in
other types of society; making the gift of blood is a natural
contribution to relieve sufferers in hospitals.7 Additionally,
potential donors may be less willing to donate to someone not
known to them. The WHO states that blood from VNRDs who give
blood out of altruism is the safest source of blood.1
The survey demonstrated that only 6.9% of the facilities
followed written SOPs, indicating poor quality systems where
these should play a vital role in blood safety. Written and followed
SOPs are an integral part of a quality system, as they facilitate
consistency in the performance of procedures in accordance with
standards. There have been several recommendations from the
WHO that each transfusion service should develop written SOPs as
guidelines covering all procedures in the testing of donated
blood.14 The WHO has speciﬁed that consistency and reliability of
performance in conformity with speciﬁed standards raises the
quality of systems in promoting blood safety. Unfortunately, an
earlier exercise carried out by the Ministry of Health (which was
reported in the Ghana National Blood Policy) to determine the
status of the blood services in regional and district health facilities
in 2006, revealed that the quality assurance programme including
SOPs that had been written and followed was under-developed
and that the equipment at all sites was generally inadequate. The
present survey conﬁrmed the existence of major problems within
quality assurance systems and the supply of logistics services.
Previously the NBSG had an external quality assessment (EQA)
programme only at its headquarters. However the NBSG checks
internal quality assessment (IQA) processes at other blood banks
elsewhere in the country. As indicated earlier, because the NBSG
does not have absolute control over the purchasing of reagents at
individual health facilities, it becomes challenging to make
recommendations on IQA.
The ﬁnding that 56.9% of facilities referred syphilis-reactive
blood donors for clinical advice suggests that, at the other 43.1% of
facilities, syphilis reactive donors remained untreated and
potentially infectious and could be transmitting the disease to
others. This represents a substantial public health failure.
The variation in costs for syphilis screening has signiﬁcant cost
implications, particularly in resource-poor settings in Sub-Saharan
Africa. There is little published information on the variation in
costs per test for syphilis, but reported costs range from US$ 0.3 to
US$ 4.5.15 In Ghana, the cost variation in syphilis test kits exists due
to a lack of guidelines to indicate the effective and accepted test
kits and their costs. As a result, many test kit types are available onthe open market without proper validation and at different costs.
For quality and consistency, the NBSG should be responsible for
purchasing approved test kits before use in order to provide safe
blood. The present survey did not indicate whether centralized
purchasing would necessarily lead to lower prices, but it may help
to reduce the cost variations and more importantly, would ensure
proper validation.
The techniques used for syphilis screening are different from
one country to another: the VDRL or RPR alone for some, and the
VDRL and TPHA for others.1 Tests and algorithms should be
selected so that they correspond with the prevalence of the disease
and match the technical expertise of the personnel and the
availability of reagents and equipment.16 The selection criteria for
a screening strategy must include simple techniques, reliability,
sustainability, and cost-effectiveness. Although they are not
recommended for blood banks in Africa, rapid test techniques
may be preferred because of their affordability, user-friendliness,
the availability of test materials, and good sensitivity and
speciﬁcity; furthermore they do not require sophisticated labora-
tory materials.16
The WHO recommends that each country should decide on the
TTIs to be screened for as part of the blood screening programme
and develop a screening strategy appropriate to its speciﬁc
situation, inﬂuenced by the incidence and prevalence of infection,
the capacity and infrastructure of the blood service, and the costs of
screening.17 The critical factor is the effective implementation of
the strategy selected and the consistency of implementation
within a well-managed quality system. The NBSG does recommend
standardized syphilis screening of all donated blood, but this
survey revealed that the guidelines were not generally being
followed and serves as an example of the consequences when
national guidelines are made without structures to enforce them
and without the resources needed to implement them locally.
This survey was not able to reach all of the transfusion facilities in
Ghana, but since the facilities that were omitted represented a very
small proportion of the total number of donations screened for
syphilis it is likely that the results provide a true reﬂection of the
national situation. The study relied on information provided by
telephone and e-mail. Resource constraints meant that it was not
possible to substantiate the ﬁndings ﬁrst-hand. Nevertheless, this
was considered the best methodology with the resources available
because some transfusion facilities are located in remote areas with
challenging roads. The estimated prevalence may not be a perfect
reﬂection of the epidemiological situation in Ghana. This is because
the donor population that was not screened could have had a higher
or lower prevalence of syphilis than the screened population. For the
population that was actually screened, variation in screening
practices may have led to both under-reporting due to a lack of
F. Sarkodie et al. / International Journal of Infectious Diseases 43 (2016) 90–9494sensitivity or over-reporting due to poor speciﬁcity of the screening
tests used.
From the questionnaire administered it was found that none of
the centres was using a second test to re-test syphilis-reactive
donations, for example a non-treponemal test to detect active
infection. Therefore it is difﬁcult to estimate how many donations
may have been infective, and how many patients receiving a blood
transfusion are potentially at risk. It is planned to examine this in a
further study.
In conclusion, there is a relatively high prevalence of syphilis
reactivity in the blood donor populations in Ghana, as elsewhere in
Sub-Saharan Africa. However, there is a low syphilis testing rate
and a relatively high use of non-approved, non-validated test kits
(RDTs) for syphilis screening, obtained at different costs, in Ghana.
If these rapid tests are effectively validated and managed, they
could be incorporated into the existing guidelines to enhance
blood safety. However the considerable mismatch between
recommendations and actual practice for syphilis screening may
compromise blood safety. Further studies on syphilis RDTs for
blood donors are suggested, in order to improve their application
in resource-poor settings.
In terms of recommendations, as shown in Table 1, screening
with the TPHA or a T. pallidum IgG-speciﬁc ELISA would be more
appropriate for the workload in teaching hospitals compared with
the other health facilities. It is recommended that teaching
hospitals perform syphilis screening using current generation
equipment for testing (e.g., TPHA or T. pallidum IgG-speciﬁc EIA),
and that the smaller facilities use validated RDTs for testing. The
challenge might be the cost implications, but we must also think of
cost-effectiveness as a public health issue. It is also recommended
that the NBSG ensure that written SOPs are developed and
incorporated into the laboratory guidelines for screening as part of
strong quality systems in the health facilities across the country,
and that all syphilis-reactive donors are referred for clinical advice.
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